Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|May 5, 2023
Is There a Vaccine to Help Reduce the Risk of Heart Attack?
Author(s)Terry Brenneman, MD
Advertisement
Heart disease is the number one cause of death in both men and women in the United States. In 2020, the CDC estimates that 697 000 of American deaths were due to heart disease; coronary heart disease (CHD) was responsible for more than half (55%) of those deaths. An ageing population, diabetes, high blood pressure, and obesity are some risk factors.
Question 1. What percentage of deaths from CHD occur in persons younger than age 65 years?
Question 2. Which of the following respiratory illnesses cause an increased risk of heart attack?
Question 3. By what percentage is the risk of being diagnosed with a heart attack in the week (7 days) following a lab confirmed case of influenza increased compared to a control interval?
Advertisement
Related to this article
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
TMS 2026: In ARIC, menopause before age 40 was linked to higher CVD and CHD risk, with insulin resistance mediating about 19% of the association.
TMS 2026: Post hoc OASIS 1 and 2 data show more women on elinzanetant reported improvement across all 8 PROMIS sleep disturbance items vs placebo at week 12.
In a pilot study of 20 midlife women with vasomotor symptoms, an AI-enabled VR program delivering CBT showed early feasibility and acceptability.
Advertisement
Advertisement
Trending on Patient Care Online
1
Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A
2
Elinzanetant Linked to Broad Improvements in Sleep Disturbance in Women With Moderate-to-Severe Vasomotor Symptoms
3
AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026
4
Insulin Resistance May Partly Explain Higher Cardiovascular Risk After Premature Menopause
5